Separate names with a comma.
Jillian Michaels Backs RFK Jr.’s Health Movement -...
Jillian Michaels Backs RFK Jr.’s Health Movement...
Unusual volume today
Quarterly Report https://www.otcmarkets.com/filing/html?id=18690124&guid=kzE-knHfIS9kdth
Form 10 has the agreement between GAC Energy and IDVV’s subsidiary (ModuLink InnoTech) - shows they will be the ONLY distributor (or sole source)...
Form 10-12G/A https://www.otcmarkets.com/filing/html?id=18684938&guid=-XE-kKI3pdaFJth Confirms IDVV has revenue generating subsidiaries - a...
New Melbourne Office is Now Open https://www.modulinktech.com/post/new-melbourne-office-is-now-open Form 3...
This applies to MindMed as well - Turn On, Tune In, Buy Out: Who Follows AbbVie Into Psychedelic M&A? A recent Bloomberg article reported that...
Turn On, Tune In, Buy Out: Who Follows AbbVie Into Psychedelic M&A? A recent Bloomberg article reported that AbbVie plans to acquire a...
The Psychedelic Sector Today: Momentum, Milestones, and What Lies Ahead...
In rumored AbbVie deal, Wall Street sees momentum for psychedelics M&A A potentially billion-dollar acquisition of Gilgamesh Pharmaceuticals...
PSIL ETF upped ATAI holdings from 11% to 13.04% in the last 2 days.
MindMed to Report Second Quarter 2025 Financial Results on July 31, 2025 NEW YORK--(BUSINESS WIRE)-- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD)...
Incredible [IMG]
AbbVie in Talks to Acquire Gilgamesh in $1 Billion Deal...
Cathie Woods bought two times in the last week: [IMG]
Atai Life Sciences CEO provides updates and outlines next steps for BPL-003 and other program [MEDIA]
GH Research (GH001, inhalable 5‑MeO‑DMT): Reported strong Phase 2b data in February 2025, showing a placebo‑adjusted MADRS reduction of ~15.5...
